搜索并找到您需要的 CMO / CDMO
为您的药物开发和制造项目寻找高技能合作伙伴。
专业治疗领域 (ATC): (V04) Diagnostic agents, (C) Cardiovascular system, (D) Dermatologicals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (M) Musculoskeletal system, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (R) Respiratory system, (S) Sensory organs, (V01) Allergens, (V06) Nutrients, (V09-10) Radiopharmaceuticals, (B) Blood and blood forming organs, (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones
OEB（职业暴露带）: 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
市场: NMPA (China), FDA (USA)
地区: 亚太地区
遵守: FDA (cGMP), ISO, NMPA (China GMP)
批量大小: Large, Small, Medium
使用: Human, Veterinary
类别/产品: 化学合成
服务: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services
专业治疗领域 (ATC): (V04) Diagnostic agents, (C) Cardiovascular system, (D) Dermatologicals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (M) Musculoskeletal system, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (R) Respiratory system, (S) Sensory organs, (V01) Allergens, (V06) Nutrients, (B) Blood and blood forming organs, (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones
受控物质: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, High potential for abuse & no medical use, Lower potential for abuse
市场: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), MFDS (South Korea), TGA (Australia)
地区: 欧洲
遵守: FDA (cGMP), PMDA/MHLW (Japan GMP), TGA (Australia GMP), EMA (EU GMP), Health Canada (Canada GMP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)
批量大小: Large, Small, Medium
使用: Human, Veterinary
类别/产品: 化学合成
服务: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services
OEB（职业暴露带）: 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
专业治疗领域 (ATC): (V04) Diagnostic agents, (C) Cardiovascular system, (D) Dermatologicals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (M) Musculoskeletal system, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (R) Respiratory system, (S) Sensory organs, (V01) Allergens, (V06) Nutrients, (B) Blood and blood forming organs, (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones
受控物质: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, High potential for abuse & no medical use, Lower potential for abuse
市场: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), MHRA (UK), MFDS (South Korea), TGA (Australia)
遵守: FDA (cGMP), ISO, ECOVADIS
批量大小: Large, Small, Medium
使用: Human, Veterinary
类别/产品: 化学合成
服务: Development services, Manufacturing services
OEB（职业暴露带）: 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
地区: 北美
市场: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), MHRA (UK), ANMAT (Argentina), INVIMA (Colombia)
服务: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging
地区: 欧洲
遵守: DIGEMID, FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), MSPAS, COFEPRIS, INVIMA, ISP (Chile BPM), ANMAT (Argentina nueva GMP), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP)
批量大小: Large, Small, Medium
使用: Human, Veterinary
BSL（生物安全等级）: 1, 2
OEB（职业暴露带）: 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
类别/产品: 生物制剂, FDF / 药品
市场: EMA (EU), MHRA (UK), TGA (Australia)
地区: 欧洲
使用: Human, Veterinary
BSL（生物安全等级）: 1
服务: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging
OEB（职业暴露带）: 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
批量大小: Small, Medium
遵守: EMA (EU GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP)
类别/产品: FDF / 药品
BSL（生物安全等级）: 3, 1, 2
市场: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), Russian Health Authorities, MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), SFDA (Saudi Arabia), MFDS (South Korea), Turkish Health Authorities, EDE (UAE), CDSCO (India), TGA (Australia), Rest of World
服务: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging
遵守: FDA (cGMP), ISO, ANVISA (Brazil B-GMP), ECOVADIS, TGA (Australia GMP), EMA (EU GMP), Health Canada (Canada GMP), MFDS/KFDA (Republic of Korea GMP)
批量大小: Large, Small, Medium
使用: Human, Veterinary
受控物质: Lowest potential for abuse
OEB（职业暴露带）: 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
地区: 北美
类别/产品: FDF / 药品
市场: EMA (EU), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), TGA (Australia)
服务: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services
地区: 欧洲
遵守: FDA (cGMP), ISO, EMA (EU GMP), World Health Organization (GMP / HACCP)
批量大小: Large, Small, Medium
使用: Human, Veterinary
BSL（生物安全等级）: 1, 2
类别/产品: 生物制剂
市场: EMA (EU), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), TGA (Australia)
服务: Logistics, Development services, Manufacturing services, Analytical / QC services, Regulatory services
地区: 欧洲
遵守: ISO
BSL（生物安全等级）: 1
批量大小: Small, Medium
类别/产品: 生物制剂
市场: EMA (EU), FDA (USA), ANVISA (Brazil), ANMAT (Argentina), MFDS (South Korea), TGA (Australia)
服务: Logistics, Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging
地区: 欧洲
遵守: FDA (cGMP), ISO, ANVISA (Brazil B-GMP), ECOVADIS, TGA (Australia GMP), INVIMA, ISP (Chile BPM), ANMAT (Argentina nueva GMP), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)
批量大小: Large, Small, Medium
使用: Human, Veterinary
专业治疗领域 (ATC): (C) Cardiovascular system, (J) Antiinfectives for systemic use, (M) Musculoskeletal system, (N) Nervous system, (A) Digestive tract and metabolism
受控物质: Lowest potential for abuse, Low potential for abuse, Lower potential for abuse
OEB（职业暴露带）: 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
类别/产品: FDF / 药品
OEB（职业暴露带）: 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
受控物质: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse
市场: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), Russian Health Authorities, MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), SFDA (Saudi Arabia), MFDS (South Korea), Turkish Health Authorities, EDE (UAE), CDSCO (India), TGA (Australia), Rest of World
服务: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging
地区: 欧洲
遵守: ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), Roszdravnadzor (Russia GMP), TITCK (Turkish Health Authorities), NMPA (China GMP), EMA (EU GMP), MFDS/KFDA (Republic of Korea GMP)
批量大小: Large, Small, Medium
使用: Human
BSL（生物安全等级）: 1, 2
专业治疗领域 (ATC): (H) Systemic hormonal preparations excl. sex hormones and insulins, (L) Antineoplastic and immunomodulating agents, (N) Nervous system
类别/产品: FDF / 药品
ALPHAVET Zrt.- Bábolna Manufacturing Plant
Alphavet Zrt.
该工厂已获得欧盟 GMP 认证，为 18 个欧盟成员国和欧盟以外的其他 7 个欧洲国家生产兽药产品。
市场: EMA (EU)
地区: 欧洲
遵守: ISO, EMA (EU GMP)
批量大小: Large, Medium
类别/产品: 营养保健品, FDF / 药品
使用: Veterinary
服务: Manufacturing services, Analytical / QC services, Regulatory services, Packaging
Avara Pharmaceutical Services | Arecibo Site
AVARA
商业规模的口服固体制剂 (OSD) 生产设施，在受控物质 (DEA II V) 方面拥有丰富的专业知识。
受控物质: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse
遵守: ICH, FDA (cGMP), PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), Roszdravnadzor (Russia GMP), EMA (EU GMP), Health Canada (Canada GMP), MFDS/KFDA (Republic of Korea GMP)
市场: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), ANVISA (Brazil), Russian Health Authorities, MFDS (South Korea), TGA (Australia)
批量大小: Large, Medium
使用: Human
类别/产品: 化学合成, 服务, FDF / 药品, 粒子工程
服务: Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging
专业治疗领域 (ATC): (C) Cardiovascular system, (H) Systemic hormonal preparations excl. sex hormones and insulins, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (M) Musculoskeletal system, (N) Nervous system, (R) Respiratory system, (S) Sensory organs, (B) Blood and blood forming organs, (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones
地区: 北美
OEB（职业暴露带）: 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)